Neonatal and adult megakaryopoiesis

Current Opinion in Hematology

Volumn 18, Issue 5, 2011, Pages 330-337

  Liu, Zhi Jian ^a   Sola Visner, Martha ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

fetus; GATA 1; megakaryocyte; neonate; thrombopoietin

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MAMMALIAN TARGET OF RAPAMYCIN; PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE AND DEVELOPMENT FACTOR; RAPAMYCIN; RECOMBINANT THROMBOPOIETIN; THROMBOPOIETIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ADULT; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOPLASM; DRUG DOSE ESCALATION; ENGRAFTMENT; ENVIRONMENTAL FACTOR; FETUS; GROUPS BY AGE; HUMAN; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MICROENVIRONMENT; MYELOPROLIFERATIVE DISORDER; NEWBORN; NONHUMAN; PATHOGENESIS; POLYPLOIDY; PRIORITY JOURNAL; RADIUS APLASIA; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; THROMBOCYTOPENIA; THROMBOCYTOPENIA ABSENT RADIUS SYNDROME; TRANSIENT MYELOPROLIFERATIVE DISORDER;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELLULAR MICROENVIRONMENT; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFANT, NEWBORN; MEGAKARYOCYTES; THROMBOCYTOPENIA; THROMBOPOIESIS; THROMBOPOIETIN;

EID: 80051799269     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283497ed5     Document Type: Review

References (43)

1. Allen Graeve JL, de Alarcon PA. Megakaryocytopoiesis in the human fetus. Arch Dis Child 1989;64:481-484. (Pubitemid 19105092)
2. De Alarcon PA, Graeve JL. Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the Feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res 1996;39:166-170. (Pubitemid 26003539)
3. Zipursky A, Brown EJ, Christensen H, Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med 1999;19:157-167; vii. (Pubitemid 29217322)
4. Geddis AE. Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Hematol Oncol Clin North Am 2009;23:321-331.
5. Ballmaier M, Schulze H, Strauss G, et al. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood 1997;90:612-619. (Pubitemid 27299101)
6. Germeshausen M, Ballmaier M, Welte K. Mpl mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum Mutat 2006;27:296.
7. Christensen RD, Henry E, Wiedmeier SE, et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 2006;26:348-353. (Pubitemid 43811510)
8. Sola-Visner MC, Christensen RD, Hutson AD, Rimsza LM. Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res 2007;61:479-484. (Pubitemid 46569304)
9. Ignatz M, Sola-Visner M, Rimsza LM, et al. Umbilical cord blood produces small megakaryocytes after transplantation. Biol Blood Marrow Transplant 2007;13:145-150. (Pubitemid 46112375)
10. Sola-Visner MC. Thrombocytopenia in the NICU: new insights into causative mechanisms and treatments. Haematol Rep 2006;2:65-69.
11. Murray NA, Watts TL, Roberts IA. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 1998;43:148-151. (Pubitemid 28069182)
12. Nishihira H, Toyoda Y, Miyazaki H, et al. Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies. Br J Haematol 1996;92:23-28. (Pubitemid 26018766)
13. Liu ZJ, Italiano J Jr, Ferrer-Marin F, et al. Developmental differences in megakaryocytopoiesis are associated with up-regulated Tpo signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 2011;117:4106-4117. This study demonstrates that human neonatal megakaryocytes are cytoplasmically mature and shows that neonatal megakaryopoiesis is characterized by an uncoupling of proliferation, polyploidization, and cytoplasmic maturation. It also describes the molecular mechanisms underlying this unique pattern, including an upregulation of the mTOR signaling pathway downstream of Tpo and elevated levels of full-length GATA-1 in neonatal compared with adult megakaryocytes.
14. Olson TA, Levine RF, Mazur EM, et al. Megakaryocytes and megakaryocyte progenitors in human cord blood. Am J Pediatr Hematol Oncol 1992;14:241-247.
15. Ma DC, Sun YH, Chang KZ, Zuo W. Developmental change of megakaryocyte maturation and DNA ploidy in human fetus. Eur J Haematol 1996;57:121-127. (Pubitemid 26313363)
16. Mattia G, Vulcano F, Milazzo L, et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 2002;99:888-897. (Pubitemid 34525550)
17. Debili N, Issaad C, Masse JM, et al. Expression of cd34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 1992;80:3022-3035. (Pubitemid 23004505)
18. Lepage A, Leboeuf M, Cazenave JP, et al. The alpha (iib) beta (3) integrin and gpib-v-ix complex identify distinct stages in the maturation of CD34 (+) cord blood cells to megakaryocytes. Blood 2000;96:4169-4177.
19. Pang L, Weiss MJ, Poncz M. Megakaryocyte biology and related disorders. J Clin Invest 2005;115:3332-3338. (Pubitemid 43121816)
20. Pang L, Xue HH, Szalai G, et al. Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins. Blood 2006;108:2198-2206. (Pubitemid 44497500)
21. Huang Z, Richmond TD, Muntean AG, et al. Stat1 promotes megakaryopoiesis downstream of gata-1 in mice. J Clin Invest 2007;117:3890-3899. (Pubitemid 350224098)
22. Muntean AG, Pang L, Poncz M, et al. Cyclin d-cdk4 is regulated by gata-1 and required for megakaryocyte growth and polyploidization. Blood 2007;109:5199-5207. (Pubitemid 46890537)
23. Sola MC, Juul SE, Meng YG, et al. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development. Early Hum Dev 1999;53:239-250. (Pubitemid 28556881)
24. Wolber EM, Dame C, Fahnenstich H, et al. Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood 1999;94:97-105. (Pubitemid 29300138)
25. Walka MM, Sonntag J, Dudenhausen JW, Obladen M. Thrombopoietin concentration in umbilical cord blood of healthy term newborns is higher than in adult controls. Biol Neonate 1999;75:54-58. (Pubitemid 28544747)
26. Sola MC, Calhoun DA, Hutson AD, Christensen RD. Plasma thrombopoietin concentrations in thrombocytopenic and nonthrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 1999;104:90-92. (Pubitemid 29037023)
27. Sola MC, Du Y, Hutson AD, Christensen RD. Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and nonthrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 2000;110:449-453. (Pubitemid 30646876)
28. Pastos KM, Slayton WB, Rimsza LM, et al. Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood 2006;108:3360-3362.
29. Sola MC, Christensen RD, Hutson AD, Tarantal AF. Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys. Pediatr Res 2000;47:208-214. (Pubitemid 30075630)
30. Harker LA, Marzec UM, Hunt P, et al. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood 1996;88:511-521. (Pubitemid 26240383)
31. Kaushansky K. Molecular mechanisms of thrombopoietin signaling. J Thromb Haemost 2009;7(Suppl. 1):235-238.
32. Slayton WB, Wainman DA, Li XM, et al. Developmental differences in megakaryocyte maturation are determined by the microenvironment. Stem Cells 2005;23:1400-1408. (Pubitemid 41504927)
33. Klusmann JH, Godinho FJ, Heitmann K, et al. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev 2010;24:1659-1672. This study describes the dependency of fetal megakaryocyte progenitors on the IGF signaling pathway, and the developmental stage-specific interplay of upregulated IGF/IGF-1R/mTOR signaling and GATA-1 that tightly controls the proliferation of fetal megakaryocyte progenitors. The article also provides insight into the mechanisms that explain the developmental stage selective effects of GATA-1 short mutations.
34. Zhang CC, Lodish HF. Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood 2004;103:2513-2521. (Pubitemid 38393001)
35. + fetal liver cells express multiple factors that promote hematopoietic stem cell expansion, including IGF2, SCF, and thrombopoietin, and are likely the primary stromal cells that support the expansion of hematopoietic stem cells in the fetal liver.
36. Mazharian A, Watson SP, Severin S. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation. Exp Hematol 2009;37:1238e5-1249e5.
37. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrowvascular niche is required for thrombopoiesis. Nat Med 2004;10:64-71. (Pubitemid 38524700)
38. Ferrer-Marin F, Gutti RK, Liu ZJ, et al. Neonatal MKs do not mature normally in the absence of thrombopoietin in vivo: potential role of developmental differences in CXCR-4 expression. ASH Annual Meeting Abstracts. Blood 2010;1598.
39. Gutti R, Sallmon H, Bailey M, et al. Neonatal and adult megakaryocytes have different microRNA expression profiles, which might contribute to their biological differences. In: Society of Pediatric Research Meeting E-PAS. 2009;2730.4.
40. Gutti R, Sallmon H, Liu ZJ, Ferrer-Marin F, et al. Developmental differences in the let-7b/IMP-1/IGF-II axis contribute to the high proliferative rate of neonatal megakaryocyte progenitors. ASH Annual Meeting Abstracts. Blood 2010;88.
41. Harker LA. Kinetics of thrombopoiesis. J Clin Invest 1968;47:458-465.
42. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969;48:963-974.
43. Hu Z, Slayton WB, Rimsza LM, et al. Differences between newborn and adult mice in their response to immune thrombocytopenia. Neonatology 2010;98:100-108. This study provides insight into the response of fetuses/neonates to consumptive thrombocytopenia, and shows that fetal/neonatal megakaryocytes have a developmental limitation in their ability to increase in size in response to increased platelet demand.